Literature DB >> 10234030

The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions.

P Svenningsson1, G G Nomikos, B B Fredholm.   

Abstract

We sought neurochemical correlates to the stimulatory action of caffeine in rats and to adaptations during development of tolerance. Acute intraperitoneal injections of caffeine (7.5 mg/kg) increased locomotion and NGFI-A mRNA, a marker of neuronal activity, in the hippocampal area CA1, but decreased NGFI-A mRNA in rostral striatum and nucleus accumbens. Rats that received caffeine (0.3 gm/l) in their drinking water for 14 d developed tolerance to the stimulatory effect of a challenge with caffeine (7.5 mg/kg) and responded with a less pronounced decrease of NGFI-A mRNA in rostral striatum and nucleus accumbens. Metabolism of caffeine to its active metabolites was increased in tolerant animals, but the total level of active metabolites in brain was not significantly altered. Thus, there are changes in caffeine metabolism after long-term caffeine treatment, but they cannot explain development of tolerance. Caffeine-tolerant animals had downregulated levels of adenosine A2A receptors and the corresponding mRNA in rostral parts of striatum, but an increased expression of adenosine A1 receptor mRNA in the lateral amygdala. No changes in mesencephalic tyrosine hydroxylase mRNA were found in caffeine-tolerant rats. Thus, we have identified neuronal pathways that are regulated by adenosine A1 and/or A2A receptors and are targets for the stimulatory action of caffeine. Furthermore, adaptive changes in gene expression in these brain areas were associated with the development of locomotor tolerance to caffeine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10234030      PMCID: PMC6782739     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  48 in total

1.  Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo.

Authors:  F Gonon
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

2.  Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study.

Authors:  S N Schiffmann; O Jacobs; J J Vanderhaeghen
Journal:  J Neurochem       Date:  1991-09       Impact factor: 5.372

3.  Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle.

Authors:  K Chergui; P Svenningsson; G G Nomikos; F Gonon; B B Fredholm; T H Svennson
Journal:  Eur J Neurosci       Date:  1997-11       Impact factor: 3.386

4.  Effects of caffeine and theophylline on activity of rats in relation to brain xanthine concentrations.

Authors:  A Thithapandha; H M Maling; J R Gillette
Journal:  Proc Soc Exp Biol Med       Date:  1972-02

5.  Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions.

Authors:  D Beitner-Johnson; E J Nestler
Journal:  J Neurochem       Date:  1991-07       Impact factor: 5.372

6.  Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor.

Authors:  C Ledent; J M Vaugeois; S N Schiffmann; T Pedrazzini; M El Yacoubi; J J Vanderhaeghen; J Costentin; J K Heath; G Vassart; M Parmentier
Journal:  Nature       Date:  1997-08-14       Impact factor: 49.962

7.  Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation.

Authors:  A J Cole; D W Saffen; J M Baraban; P F Worley
Journal:  Nature       Date:  1989-08-10       Impact factor: 49.962

8.  On the mechanism by which methylxanthines enhance apomorphine-induced rotation behaviour in the rat.

Authors:  B B Fredholm; M Herrera-Marschitz; B Jonzon; K Lindström; U Ungerstedt
Journal:  Pharmacol Biochem Behav       Date:  1983-09       Impact factor: 3.533

9.  Cloning and expression of an A1 adenosine receptor from rat brain.

Authors:  L C Mahan; L D McVittie; E M Smyk-Randall; H Nakata; F J Monsma; C R Gerfen; D R Sibley
Journal:  Mol Pharmacol       Date:  1991-07       Impact factor: 4.436

10.  Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding.

Authors:  G B Kaplan; D J Greenblatt; M A Kent; M M Cotreau-Bibbo
Journal:  J Pharmacol Exp Ther       Date:  1993-09       Impact factor: 4.030

View more
  43 in total

1.  Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers.

Authors:  Francisco Ciruela; Vicent Casadó; Ricardo J Rodrigues; Rafael Luján; Javier Burgueño; Meritxell Canals; Janusz Borycz; Nelson Rebola; Steven R Goldberg; Josefa Mallol; Antonio Cortés; Enric I Canela; Juan F López-Giménez; Graeme Milligan; Carme Lluis; Rodrigo A Cunha; Sergi Ferré; Rafael Franco
Journal:  J Neurosci       Date:  2006-02-15       Impact factor: 6.167

2.  Methylxanthines Increase Expression of the Splicing Factor SRSF2 by Regulating Multiple Post-transcriptional Mechanisms.

Authors:  Jia Shi; Kirk Pabon; Kathleen W Scotto
Journal:  J Biol Chem       Date:  2015-03-28       Impact factor: 5.157

3.  Dysregulation of brain adenosine is detrimental to the expression of conditioned freezing but not general Pavlovian learning.

Authors:  Philipp Singer; Chuchu Zhang; Detlev Boison; Benjamin K Yee
Journal:  Pharmacol Biochem Behav       Date:  2013-01-02       Impact factor: 3.533

4.  Injection of Cocaine-Amphetamine Regulated Transcript (CART) peptide into the nucleus accumbens does not inhibit caffeine-induced locomotor activity: Implications for CART peptide mechanism.

Authors:  Martin O Job
Journal:  Pharmacol Biochem Behav       Date:  2016-05-07       Impact factor: 3.533

5.  Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor.

Authors:  B Johansson; L Halldner; T V Dunwiddie; S A Masino; W Poelchen; L Giménez-Llort; R M Escorihuela; A Fernández-Teruel; Z Wiesenfeld-Hallin; X J Xu; A Hårdemark; C Betsholtz; E Herlenius; B B Fredholm
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

6.  Assessment of the Drug-Drug Interaction Potential Between Theacrine and Caffeine in Humans.

Authors:  Hui He; Dejian Ma; Laura Brooks Crone; Matthew Butawan; Bernd Meibohm; Richard J Bloomer; Charles R Yates
Journal:  J Caffeine Res       Date:  2017-09-01

7.  Acute caffeine treatment increases extracellular nucleotide hydrolysis from rat striatal and hippocampal synaptosomes.

Authors:  Rosane Souza da Silva; Alessandra Nejar Bruno; Ana Maria Oliveira Battastini; João José Freitas Sarkis; Diogo Rizzato Lara; Carla Denise Bonan
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

8.  Adenosine receptor blockade reverses hypophagia and enhances locomotor activity of dopamine-deficient mice.

Authors:  Douglas S Kim; Richard D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

Review 9.  Exploring cocoa properties: is theobromine a cognitive modulator?

Authors:  Ilaria Cova; V Leta; C Mariani; L Pantoni; S Pomati
Journal:  Psychopharmacology (Berl)       Date:  2019-01-31       Impact factor: 4.530

10.  Psychopharmacology of theobromine in healthy volunteers.

Authors:  Matthew J Baggott; Emma Childs; Amy B Hart; Eveline de Bruin; Abraham A Palmer; Joy E Wilkinson; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2013-02-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.